Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,General Medicine
Reference47 articles.
1. Aymard N, Viala A, Clement MN, Jacquot M, Vacheron MN, Gauillard J, Caroli F (2002) Long-term pharmacoclinical follow-up in schizophrenic patients treated with risperidone. Plasma and red blood cell concentrations of risperidone and its 9-hydroxymetabolite and their relationship to whole blood serotonin and tryptophan, plasma homovanillic acid, 5-hydroxyindoleacetic acid, dihydroxyphenylethyleneglycol and clinical evaluations. Prog Neuropsychopharmacol Biol Psychiatry 26:975–988
2. Bader W, Melchner D, Nonenmacher T, Haen E (2005) Determination of five commonly used antipsychotics in human serum by high performance-liquid chromatography (HPLC) and electrochemical detection. International meeting on pharmacovigilance in psychiatry, therapeutic drug monitoring and pharmacogenetics of psychotropic drugs, Lausanne, Switzerland, 2004. Abstract Pharmacopsychiatry 38:4
3. Balant-Gorgia AE, Gex-Fabry M, Genet C, Balant LP (1999) Therapeutic drug monitoring of risperidone using a new, rapid HPLC method: reappraisal of interindividual variability factors. Ther Drug Monit 21:105–115
4. Beneke M, Rasmus W (1992) “Clinical Global Impressions” (ECDEU): some critical comments. Pharmacopsychiatry 25:171–176
5. Castberg I, Spigset O (2005) Serum concentrations of risperidone and 9-hydroxyrisperidone after administration of the long-acting injectable form of risperidone: evidence from a routine therapeutic drug monitoring service. Ther Drug Monit 27:103–106
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献